Skip to content
PICO Portalanswers from OpenAlex

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer

PaperCitations, authors & open-access status

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer have?

PICO Portalcitation count

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer has 72 citations in the OpenAlex counts PICO Portal stores.

When was LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer published?

PICO Portalyear

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer has 2018 year in the PICO Portal index.

What is the open-access status of LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

PICO Portaloa status

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer has green oa status in the PICO Portal index.

What is the DOI of LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

PICO Portaldoi

The DOI for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is on the source record.

What is the PMID of LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

PICO Portalpmid

The PMID for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is on the source record.

What is the OpenAlex record for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

PICO Portalopenalex

The OpenAlex for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial